Skip to content
10-Q

Quarterly Report

PHARMAGREEN BIOTECH INC. PHBI

0001477932-22-006233

← back to feed
Filed
Aug 17, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Aug 15, 2022 424.42M sh
Shares Diluted Q3 2022 · Jun 30, 2022 613.47M sh
Shares Diluted Q3 2022 · Jun 30, 2022 395.04M sh
Shares Diluted Q3 2022 · Jun 30, 2021 351.76M sh
Shares Diluted Q3 2022 · Jun 30, 2021 271.42M sh
Cash And Equivalents Q3 2022 · Jun 30, 2022 $24.26K
Cash And Equivalents Q3 2022 · Sep 30, 2021 $25.3K
Cash And Equivalents Q3 2022 · Jun 30, 2021 $19.22K
Cash And Equivalents Q3 2022 · Sep 30, 2020 $12.2K
Stockholders Equity Q3 2022 · Jun 30, 2022 −$1.89M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$1.65M
Current Liabilities Q3 2022 · Jun 30, 2022 $1.99M
Current Liabilities Q3 2022 · Sep 30, 2021 $2.03M
Total Liabilities Q3 2022 · Jun 30, 2022 $2.13M
Total Liabilities Q3 2022 · Sep 30, 2021 $2.07M
Total Assets Q3 2022 · Jun 30, 2022 $191.17K
Total Assets Q3 2022 · Sep 30, 2021 $373.08K
Eps Diluted Q3 2022 · Jun 30, 2022 $0.00
Eps Diluted Q3 2022 · Jun 30, 2022 $0.00
Eps Diluted Q3 2022 · Jun 30, 2021 $0.00
Eps Diluted Q3 2022 · Jun 30, 2021 −$0.01
Eps Basic Q3 2022 · Jun 30, 2022 $0.00
Eps Basic Q3 2022 · Jun 30, 2022 $0.00
Eps Basic Q3 2022 · Jun 30, 2021 $0.00
Eps Basic Q3 2022 · Jun 30, 2021 −$0.01
Operating Income Q3 2022 · Jun 30, 2022 −$241.22K
Operating Income Q3 2022 · Jun 30, 2022 −$903.74K
Operating Income Q3 2022 · Jun 30, 2021 −$232.38K
Operating Income Q3 2022 · Jun 30, 2021 −$470.95K
Net Income Q3 2022 · Mar 31, 2022 −$1.04M
Net Income Q3 2022 · Jun 30, 2021 −$142.23K
Net Income Q3 2022 · Jun 30, 2021 −$3.7M
Net Income Q3 2022 · Mar 31, 2021 −$3.14M
Net Income Q3 2022 · Dec 31, 2020 −$417.11K
Operating Cash Flow Q3 2022 · Jun 30, 2021 −$151.24K
Sga Expense Q3 2022 · Jun 30, 2021 $20.72K
Sga Expense Q3 2022 · Jun 30, 2021 $64.38K